Track topics on Twitter Track topics that are important to you
HIGHLIGHTS: Sanfeliu leaves Ysios, Bionure round of funding, Alzheimer research, milestones at Oryzon and Spherium, results of publicly traded companies
The neuroprotection biotech also strengthens its scientific team with the arrival of Dr Amit Bar-Or, a multiple sclerosis specialist, to the Scientific Advisory Board
SummaryBionure Farma SL Bionure is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates ...
Bionure is a late-preclinical drug development company focused at developing first-in-class SGK agonists for the treatment of rare ophthalmological diseases: Acute Optic Neuritis ...
We have published hundreds of Bionure, Inc. news stories on BioPortfolio along with dozens of Bionure, Inc. Clinical Trials and PubMed Articles about Bionure, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bionure, Inc. Companies in our database. You can also find out about relevant Bionure, Inc. Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...